Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2015
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoIssaka Zongo, Paul Milligan, Yves Daniel Compaore, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2024
Efficacy of ivermectin and its metabolites against <i>Plasmodium falciparum</i> liver stages in primary human hepatocytesPradeep Annamalai Subramani, Phornpimon Tipthara, Surendra Kumar Kolli, et al.
British Journal of Clinical Pharmacology|July 12, 2017
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteersPalang Chotsiri, Thanaporn Wattanakul, Richard M Hoglund, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
A small amount of fat does not affect piperaquine exposure in patients with malariaAnna Annerberg, Khin Maung Lwin, Niklas Lindegardh, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2014
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaFrank Kloprogge, Vincent Jullien, Patrice Piola, et al.
Malaria Journal|March 24, 2018
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern MyanmarJesmin Permala Lohy Das, Myat P Kyaw, Myat H Nyunt, et al.
British Journal of Clinical Pharmacology|October 10, 2014
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsRichard M Hoglund, Pauline Byakika-Kibwika, Mohammed Lamorde, et al.
Pharmacology Research & Perspectives|January 26, 2021
Identification of the metabolites of ivermectin in humansPhornpimon Tipthara, Kevin C Kobylinski, Markus Godejohann, et al.
Malaria Journal|April 28, 2016
Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malariaThanaporn Wattanakul, Pramote Teerapong, Katherine Plewes, et al.
Plos Neglected Tropical Diseases|September 22, 2025
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)Frauke Assmus, Cintia Cruz, James A Watson, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|April 29, 2015
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina FasoIssaka Zongo, Paul Milligan, Yves Daniel Compaore, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2024
Efficacy of ivermectin and its metabolites against <i>Plasmodium falciparum</i> liver stages in primary human hepatocytesPradeep Annamalai Subramani, Phornpimon Tipthara, Surendra Kumar Kolli, et al.
British Journal of Clinical Pharmacology|July 12, 2017
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteersPalang Chotsiri, Thanaporn Wattanakul, Richard M Hoglund, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
A small amount of fat does not affect piperaquine exposure in patients with malariaAnna Annerberg, Khin Maung Lwin, Niklas Lindegardh, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2014
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaFrank Kloprogge, Vincent Jullien, Patrice Piola, et al.
Malaria Journal|March 24, 2018
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern MyanmarJesmin Permala Lohy Das, Myat P Kyaw, Myat H Nyunt, et al.
British Journal of Clinical Pharmacology|October 10, 2014
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsRichard M Hoglund, Pauline Byakika-Kibwika, Mohammed Lamorde, et al.
Pharmacology Research & Perspectives|January 26, 2021
Identification of the metabolites of ivermectin in humansPhornpimon Tipthara, Kevin C Kobylinski, Markus Godejohann, et al.
Malaria Journal|April 28, 2016
Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malariaThanaporn Wattanakul, Pramote Teerapong, Katherine Plewes, et al.
Plos Neglected Tropical Diseases|September 22, 2025
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)Frauke Assmus, Cintia Cruz, James A Watson, et al.
Pageof 25